Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Alkermes Plc
(NQ:
ALKS
)
29.32
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 26, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
29.32
Bid (Size)
28.14 (1)
Ask (Size)
30.68 (1)
Prev. Close
29.32
Today's Range
29.32 - 29.32
52wk Range
21.75 - 32.23
Shares Outstanding
166,121,384
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Alkermes Earnings Perspective: Return On Capital Employed
April 27, 2023
Via
Benzinga
Analyst Expectations for Alkermes's Future
April 27, 2023
Via
Benzinga
Performance
YTD
+13.34%
+13.34%
1 Month
+2.37%
+2.37%
3 Month
+7.83%
+7.83%
6 Month
+22.32%
+22.32%
1 Year
-1.78%
-1.78%
More News
Read More
The Latest Analyst Ratings for Alkermes
April 27, 2023
Via
Benzinga
A Preview Of Alkermes's Earnings
April 25, 2023
Via
Benzinga
Alkermes Stock Sees Rising Relative Strength Rating
March 28, 2023
Via
Investor's Business Daily
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
March 15, 2023
Via
InvestorPlace
Earnings Scheduled For February 16, 2023
February 16, 2023
Via
Benzinga
Alkermes Earnings Preview
February 15, 2023
Via
Benzinga
Analyst Ratings for Alkermes
December 06, 2022
Via
Benzinga
Alkermes Plans Separating Its Oncology Unit; Lifts FY22 Earnings Guidance
November 02, 2022
Via
Benzinga
Alkermes: Commercialization Program On Track, Sales Coming In Strong
March 04, 2023
Via
Talk Markets
Alkermes Stock Sees Rising Relative Price Strength
February 17, 2023
Via
Investor's Business Daily
Seattle Genetics' 'Refreshing' Enthusiasm Drives Stock Surge; Alkermes Briefly Breaks Out
February 16, 2023
Via
Investor's Business Daily
Alkermes's Return On Capital Employed Insights
November 10, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2022
November 03, 2022
Via
Benzinga
Recap: Alkermes Q2 Earnings
July 27, 2022
Via
Benzinga
Recap: Alkermes Q3 Earnings
November 02, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2022
October 14, 2022
Via
Benzinga
Domino's Pizza To Rally 20%? Here Are 5 Other Price Target Changes For Friday
October 14, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2022
August 16, 2022
Via
Benzinga
Looking Into Alkermes's Return On Capital Employed
July 28, 2022
Via
Benzinga
Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy
July 27, 2022
Via
Benzinga
Earnings Preview: Alkermes
July 26, 2022
Via
Benzinga
Biotech Hasn't Been This Blazing Hot Since Early 2021 — Here Are The Top 5
July 15, 2022
Via
Investor's Business Daily
Sarissa Capital Comments on Alkermes Annual Meeting
July 06, 2022
From
Sarissa Capital Management LP
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
